[8-K] DENTSPLY SIRONA Inc. Reports Material Event

Rhea-AI Filing Summary

DENTSPLY SIRONA (XRAY) furnished an 8-K announcing it issued a press release with financial results for the third fiscal quarter ended September 30, 2025. The press release is provided as Exhibit 99.1 under Item 2.02. The company notes this information is being furnished, not filed, under the Exchange Act, and therefore is not subject to Section 18 liabilities or incorporation by reference unless specifically referenced.

0000818479false00008184792025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

November 6, 2025

Date of Report (date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of Principal Executive Offices)

(Zip Code)

(844) 848-0137

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Item 2.02     Results of Operations and Financial Condition

On November 6, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its third fiscal quarter ended September 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1.

The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01     Financial Statements and Exhibits

(d) Exhibits:

Exhibit No.						Description
99.1						DENTSPLY SIRONA Inc. Press release issued November 6, 2025, as referenced in Item 2.02
104						Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

            DENTSPLY SIRONA Inc.

By:						/s/ Daniel T. Scavilla
						Daniel T. Scavilla
						President and
						Chief Executive Officer

Date: November 6, 2025

FAQ

What did DENTSPLY SIRONA (XRAY) announce in this 8-K?

It furnished a press release with financial results for the third fiscal quarter ended September 30, 2025, as Exhibit 99.1 under Item 2.02.

Which exhibit contains the Q3 2025 results for XRAY?

Exhibit 99.1 contains the press release with third quarter 2025 financial results.

Are the disclosed items considered filed under the Exchange Act?

No. The information under Item 2.02, including Exhibit 99.1, is furnished, not filed, and not subject to Section 18 liabilities.

What period does the press release cover for XRAY?

It covers the company’s third fiscal quarter ended September 30, 2025.

When was the press release referenced by XRAY issued?

It was issued on November 6, 2025, and furnished with this 8-K.

What is the form type of the filing by XRAY?

Form 8-K with Item 2.02 (Results of Operations and Financial Condition).